Capro Corp. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW246.98 |
Market Cap |
KRW173.6 B |
Shares Outstanding |
40 M |
Public Float |
31.5 M |
Address |
14/F, Neewei Building Seoul SL 04539 Korea, Republic Of |
Employees | - |
Website | http://www.hcccapro.co.kr |
Updated | 07/08/2019 |
Capro Corp. engages in the manufacture and sale of caprolactam and ammonium sulfate. Its products include Caprolactam, ammonlum sulphate, ammonlum sulphate nitrate, and methylethylketoxime. The company was founded on December 30, 1969 and is headquartered in Seoul, South Korea. |